JPRN-UMIN000011031已完成2 期
A phase II study of neoadjuvant docetaxel/cyclophosphamide (DC) followed by epirubicin/cyclophosphamide (EC) for triple-negative breast cancer - DC followed by EC as NAC PII
Tokyo Women's Medical University0 个研究点目标入组 34 人开始时间: 2013年6月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Severe complications history of hypersensitivity reaction for important drug in this study Bilateral breast cancer Inflammatory breast cancer Pregnant or nursing women
研究者
相似试验
招募中
不适用
A phase 2 study of neoadjuvant docetaxel, oxaliplatin, S-1 in patients with unresectable locally advanced or distant metastasis limited to lymph node gastric cancerNeoplasmsKCT0006894Asan Medical Center63
进行中（未招募）
2 期
eoadjuvant docetaxel, oxaliplatin and S-1 therapy for large type 3 or type 4 gastric cancerGastric cancerJPRN-jRCTs051190060GOTO Masahiro46
已完成
2 期
Phase II study of the combination of docetaxel, cisplatin plus S-1(DCS) for advanced or recurrent gastric cancer(KDOG 0601)Gastric cancerJPRN-UMIN000001119Department of Gastroenterology, Kitasato University School of Medicine45
尚未招募
不适用
A phase II trial of neoadjuvant docetaxel/5-FU/cisplatin in combination with prophylactic Pegteograstim in unresectable, locally advanced nasal cavity/paranasal squamous cell carcinoma (SCC)NeoplasmsKCT0003377The Catholic University of Korea, St. Vincent's Hospital28
已完成
2 期
Phase II trial of neoadjuvant docetaxel + cisplatin + fluorouracil (DCF) therapy for esophageal cancerEsophageal cancerJPRN-UMIN000028252agoya University28